Navigation Links
World's First Implantation of SPR™ System for Chronic Pain
Date:10/20/2011

CLEVELAND, Oct. 20, 2011 /PRNewswire-USNewswire/ -- A 76-year-old man suffering from agonizing post-stroke shoulder pain for more than ten years is now pain-free, thanks to the world's first implantation of an investigational pain therapy device from SPR™ Therapeutics.

(Logo: http://photos.prnewswire.com/prnh/20111020/DC90730LOGO)  

The implant was placed at Carolinas Medical Center and the patient was treated at Carolinas Rehabilitation in Charlotte, North Carolina as part of a multi-center clinical study for the treatment of post-stroke shoulder pain sponsored by NDI Medical, LLC, also involving MossRehab in Philadelphia, Weill Cornell Medical Center in New York City, and MetroHealth Medical Center in Cleveland.

"This is the first promising pain treatment technology designed to reduce or eliminate the excruciating shoulder pain that many stroke survivors suffer from," said Dr. Vu Q.C. Nguyen, MD, Director of Stroke Rehabilitation at Carolinas Rehabilitation and principal investigator of the clinical study. "This study will enable us to evaluate whether this advanced technology has come up to the level to meet our patients' needs."

The study participant was given SPR's short-term, temporary therapy in September 2010 which significantly reduced his pain after just a few weeks.  In December 2011, Dr. William Bock, M.D., cardiologist at Carolinas Medical Center then implanted SPR's fully implantable device in the patient, who was pain-free within a few weeks of this surgery.  He has been pain-free since then, except for a short period in February through April 2011 when the system was turned off due to an unrelated illness. Within a few weeks of the system being turned back on, the patient's shoulder pain was completely eliminated.  

The patient's overall quality of life has also improved, including improvements in his sleep, mood, and relationships with others, according to study measures. The clinical study is evaluating the safety and effectiveness of this fully implantable therapy in a group of subjects with post-stroke shoulder pain, and the results experienced by the first subject are very encouraging.

Shoulder pain is a common complication following stroke, affecting almost one third of stroke survivors. Yet, post-stroke shoulder pain has not been adequately addressed by traditional treatment options such as local injections, oral analgesics, physical and occupational therapies, acupuncture, and surface neuromuscular electrical stimulation.

The investigational SPR™ System uses a proprietary method of Intramuscular Nerve (IMN™) Therapy which stimulates peripheral nerves within muscle to treat pain, and is being studied in patients who are unresponsive to or cannot tolerate these conventional therapies.  There are risks associated with participating in the study and receiving the SPR System, and study subjects are informed of all the potential risks before enrolling in the study.

"The implantation of our first fully implantable SPR System for chronic pain is a significant milestone for the treatment of post-stroke shoulder pain and potentially other pain indications in the future," said Maria Bennett, MS, President and CEO of SPR™ Therapeutics. "Relief of shoulder pain is critical in improving these patients' lives."

SPR Therapeutics has developed the SPR System (an investigational device that is limited by U.S. law to investigational use): a two-stage system for the treatment of chronic pain, using the Smartpatch™ short-term system in the first stage, and a fully implantable Micropulse® long-term implant system in its second stage.  The System is non-narcotic and reversible, lead placement in muscle is minimally invasive and visual muscle activation confirms target lead location without imaging.

The SPR System could "potentially revolutionize the treatment of chronic shoulder pain," according to Dr. John Chae, MD, MS, SPR™ Therapeutics' chief medical advisor and professor of Physical Medicine and Rehabilitation at Case Western Reserve University and MetroHealth Medical Center. "Additional studies are being initiated to evaluate this therapy in subjects with shoulder pain that is not related to stroke."

About SPR™ Therapeutics
SPR™ Therapeutics (Stimulation for Pain Relief) is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation devices. SPR™ Therapeutics was formed in January 2010 as a portfolio company of NDI Medical, LLC, a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions. For more information, visit www.sprtherapeutics.com.

About Carolinas Rehabilitation
Founded in 1950, Carolinas Rehabilitation has 192 rehabilitation beds, including 90 at the main Carolinas Rehabilitation facility, located on the campus of Carolinas Medical Center.  The total also includes 39 beds at CMC-Mercy, 40 beds at Carolinas Rehabilitation - Mount Holly, 10 beds at Stanly Regional Medical Center and 13 pediatric beds at Levine Children's Hospital.  Carolinas Rehabilitation also has eleven outpatient rehabilitation locations.  


'/>"/>
SOURCE SPR Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
2. The Virginia Dental Association Honors Henry Schein Cares With the Organizations First Corporate Partner Award
3. InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
4. Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011
5. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
6. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
7. Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
8. National Institute of Cancer Is the First Center in Mexico to Offer Positron Emission Mammography
9. First Results From Ongoing Phase III Trial Show Malaria Vaccine Candidate, RTS,S* Reduces the Risk of Malaria by Half in African Children Aged 5 to 17 Months
10. Alquest Announced as MedNet Solutions First iMedNet CRO Partner
11. HipSextant™ Navigation System Receives Its First Commercial Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... -- The concept of rare diseases and the idea that ... has been taking shape in Europe ... initiatives related to orphan medicinal products have been emerging at ... states individually. Many member states in the EU have led ... medicinal products, the result of which took the shape of ...
(Date:12/2/2016)... -- Around the corners of world, cancer has infused ... present over earth. Cancer has become one of those ... time this is because of the increasing incidence rates ... steady increase in global cancer incidence with its associated ... of treatment, there is increasing interest in this stringent ...
(Date:12/2/2016)... 2, 2016 bioLytical Laboratories (das "Unternehmen"), ein Weltführer ... seinen  INSTI HIV-Selbsttests  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) ...
Breaking Medicine Technology:
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
Breaking Medicine News(10 mins):